financetom
Business
financetom
/
Business
/
Secure identity platform Clear Secure's Q2 revenue growth beats estimates on higher sign-ups
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Secure identity platform Clear Secure's Q2 revenue growth beats estimates on higher sign-ups
Aug 5, 2025 3:28 AM

Overview

* Clear Secure ( YOU ) fiscal Q2 revenue up 17.5%, beating analyst expectations, per LSEG data

* Adjusted EBITDA for fiscal Q2 exceeds analyst estimates, per LSEG data

* Co repurchased 1 mln shares, returning $42.7 mln to shareholders in fiscal Q2

Outlook

* Clear Secure sees Q3 2025 revenue of $223-226 mln

* Company expects Q3 2025 bookings of $253-258 mln

* Clear Secure ( YOU ) reaffirms full-year free cash flow of at least $310 mln

* Company anticipates adjusted EBITDA margin expansion for full year 2025

Result Drivers

* MEMBER GROWTH - Active CLEAR+ Members increased by 7.5% year-over-year, contributing to revenue growth

* SERVICE EXPANSION - Expansion of CLEAR+ for international travelers and launch of new services like Concierge and CLEAR ID supported operational achievements

* CLEAR1 TRACTION - Record number of deals signed for CLEAR1 product in Q2, indicating strong business momentum

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $219.50 $214.90

Revenue mln mln (8

Analysts

)

Q2 Net $37.90

Income mln

Q2 Beat $60.10 $52.60

Adjusted mln mln (7

EBITDA Analysts

)

Q2 Basic $0.26

EPS

Q2 Free $117.90

Cash mln

Flow

Q2 Gross $222.90

Bookings mln

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 4 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the software peer group is "buy."

* Wall Street's median 12-month price target for Clear Secure Inc ( YOU ) is $28.00, about 7.1% below its August 4 closing price of $29.99

* The stock recently traded at 26 times the next 12-month earnings vs. a P/E of 16 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Applied DNA Sciences Unit Submits Validation Package to Expand Use of Mpox Virus Assay; Shares Rise
Applied DNA Sciences Unit Submits Validation Package to Expand Use of Mpox Virus Assay; Shares Rise
Aug 29, 2024
09:51 AM EDT, 08/23/2024 (MT Newswires) -- Applied DNA Sciences ( APDN ) rose by more than 30% in recent trading after the company said its subsidiary, Applied DNA Clinical Labs, has submitted a validation package to the New York State Department of Health seeking to expand the permitted use of its Linea Mpox Virus 1.0 Assay to include both...
Champion Homes Insider Sold Shares Worth $262,610, According to a Recent SEC Filing
Champion Homes Insider Sold Shares Worth $262,610, According to a Recent SEC Filing
Aug 29, 2024
10:03 AM EDT, 08/23/2024 (MT Newswires) -- Joseph A. Kimmell, EVP, Operations, on August 21, 2024, sold 2,964 shares in Champion Homes ( SKY ) for $262,610. Following the Form 4 filing with the SEC, Kimmell has control over a total of 47,262 shares of the company, with 47,262 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/90896/000095017024100036/xslF345X05/ownership.xml Price: 89.03, Change: +0.69, Percent...
Altamira Medica, Pharma Nordic to Launch Bentrio Nasal Spray in Sweden, Denmark
Altamira Medica, Pharma Nordic to Launch Bentrio Nasal Spray in Sweden, Denmark
Aug 29, 2024
09:59 AM EDT, 08/23/2024 (MT Newswires) -- Altamira Therapeutics ( CYTO ) said Friday that its associate company, Altamira Medica, and its Norwegian partner Pharma Nordic have agreed to add Sweden and Denmark to the areas covered by their distribution agreement for the Bentrio nasal spray. Pharma Nordic plans to launch Bentrio in Sweden and Denmark next year following the...
Hni Insider Sold Shares Worth $259,251, According to a Recent SEC Filing
Hni Insider Sold Shares Worth $259,251, According to a Recent SEC Filing
Aug 29, 2024
09:55 AM EDT, 08/23/2024 (MT Newswires) -- Mary A Bell, Director, on Aug. 21, 2024, sold 5,000 shares in Hni (HNI) for $259,251. Following the Form 4 filing with the SEC, Bell has control over a total of 74,462 shares of the company, with 74,462 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/48287/000004828724000169/xslF345X05/wk-form4_1724420311.xml Price: 52.14, Change: +0.31, Percent Change: +0.59 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved